We Have Moved! V2V Chicago Office Expands to More Collaborative Space

Kicking off 2023, the Vision2Voice Chicago group moved to a new office that offers an even better opportunity to deliver top quality service. Our team is growing, so we’ve invested in an innovative workspace that’s conducive to creative collaboration between V2V team members and to connecting in-person with our clients. Whether you’re returning to the office, working remotely full time, or in a hybrid arrangement, we’re here for you. Our facility is conveniently located just minutes from O’Hare International Airport. We love it when our clients come to see us, and we welcome your visit! 

ABOUT THE AUTHOR

Picture of Daniel J. Rehal

Daniel J. Rehal

As President of Vision2Voice, Daniel thoroughly understands the pharmaceutical industry from the ground floor up. By ascending the ranks at Merck to his global responsibilities at Takeda, Dan has significant experience in both marketing and sales roles supporting a multitude of pharmaceutical brands as an award-winning Sales Representative, Training Manager, District Manager, Senior Product Manager, and Marketing Director.

Recent Posts

Man in suit holding back dominos

Will Your Launch Strategy Succeed or Fail?

The Challenge: A Faster, More Complex Launch Environment In today’s pharmaceutical market, strong science is the foundation, but it doesn’t always guarantee a successful launch....

Read More
Story 2

Industry Insights – June 2026

From evolving China deal dynamics and prolonged job searches to the growing push for AI-driven drug repurposing, explore how shifts in BioPharma are redefining innovation,...

Read More
FDA Commissioner Marty Makary, M.D.

Industry Insights – May 2026

Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment,...

Read More